Metaphore Pharmaceuticals' Series B Round

Metaphore Pharmaceuticals raised a round of funding on December 06, 2000.

Metaphore leads the emerging pharmaceutical frontier with its introduction of SOD mimetics, aka superoxide dismutase mimetic (SODm), which mimic, supplement, and enhance the human body's enzyme activi…

Articles about Metaphore Pharmaceuticals' Series B Round: